Bull Notes for 3 Wall Street Rookies

Analysts set high price targets for TWST, AXNX, and ORTX

Nov 26, 2018 at 10:11 AM
facebook twitter linkedin

Today we're going to be looking at three bullish analyst notes out of the healthcare sector. More specifically, Twist Bioscience Corp (NASDAQ:TWST), Axonics Modulation Technologies Inc (NASDAQ:AXNX), and Orchard Therapeutics (NASDAQ:ORTX) all received upbeat attention from the brokerage community, so we'll check in on shares of TWST, AXNX, and ORTX below.

Let's begin with TWST stock. Cowen and Company initiated coverage on the synthetic DNA manufacturing specialist with an "outperform" designation, becoming the first brokerage firm to track the equity. Twist Bioscience shares began trading publicly on Oct. 31 at $13, rallying to as high as $29.21 on Nov. 16. Since then they've found support atop the newly formed 10-day moving average, and are up 8.9% today at $28.30.

Turning to AXNX stock, it also just had its initial public offering (IPO) late last month, and opened for trade at $16.05 on Oct. 31. Its technical performance hasn't been as impressive as TWST, as it's mostly traded sideways, closing Friday just below $15. Analysts are expecting a turnaround for the medical technology stock, though, with Morgan Stanley and Wells Fargo each issuing the equivalent of "buy" ratings this morning, on top of respective price targets of $21 and $22. Axonics Modulation Technologies was last seen down 1.8% at $14.65, however.

Finally, Orchard Therapeutics began trading publicly at $17 on Oct. 31. Following a brief pullback after its post-IPO pop, the stock reversed course to hit an all-time high of $19.24 on Nov. 19. Today, the shares are down 0.4% at $16.70, even after Cowen's new "outperform" rating and $27 price target -- almost 62% above current levels. Meanwhile, Wedbush also initiated coverage with an "outperform" rating and $25 price target.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners